DOSE INTENSITY AND TOLERANCE IMPROVEMENT OF CETUXIMAB, IRINOTECAN, 5-FU AND FOLINIC ACID IN PATIENTS WITH METASTATIC CRC; A PHARMACOKINETIC AND PHARMACOGENETIC APPROACH

Authors
Publication date
1 September 2008
Publisher
'Elsevier BV'

Abstract

International audienc

    Similar works

    Full text

    thumbnail-image

    Available Versions

    HAL-Univ-Nantes

    redirect
    oaioai:HAL:hal-00618341v1
    Last time updated on 12/11/2016

    HAL Université de Tours

    redirect
    oaioai:HAL:hal-00618341v1
    Last time updated on 12/11/2016